Inventor
ISACSON OLE
US12 patents
⚠️ This page may combine multiple inventors who share the name “ISACSON OLE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MCLEAN HOSPITAL CORP
4 patentsUS6294383B1Sep 25, 2001
Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases
MCLEAN HOSPITAL CORP25 citations91
US9968637B2May 15, 2018
Dopaminergic neurons differentiated from pluripotent stem cells and uses thereof
MCLEAN HOSPITAL CORP13 citations81
US9249389B2Feb 2, 2016
Methods for isolating early neurons and neuroblasts
MCLEAN HOSPITAL CORP9 citations76
US7585962B2Sep 8, 2009
Multimerized enhancer domains for cell-specific expression
MCLEAN HOSPITAL CORP0 citations47
ISACSON OLE
3 patentsUS8153422B2Apr 10, 2012
Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases
ISACSON OLE9 citations78
US8586558B2Nov 19, 2013
RAB3B for treatment and prevention of Parkinson's disease
ISACSON OLE0 citations47
US8545834B2Oct 1, 2013
G-substrate for the treatment and prevention of parkinson's disease
ISACSON OLE0 citations47
UNIV ROSALIND FRANKLIN MEDICINE & SCIENCE
3 patentsUS9840710B2Dec 12, 2017
Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
UNIV ROSALIND FRANKLIN MEDICINE & SCIENCE6 citations69
US10787669B2Sep 29, 2020
Antisense compounds targeting Leucine-Rich repeat kinase 2(LRRK2) for the treatment of Parkinsons disease
UNIV ROSALIND FRANKLIN MEDICINE & SCIENCE0 citations48
US10370667B2Aug 6, 2019
Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
UNIV ROSALIND FRANKLIN MEDICINE & SCIENCE0 citations48